GlassScriptPhysician profile
Bochen Tong
NPI 1689092611
$12,570.01
in general payments reported to CMS, 2019-2025
51 companies · $941 in 2025
The $941 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.57 · 2021: $2,561 · 2022: $3,214 · 2023: $3,057 · 2024: $2,781 · 2025: $941.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,771 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,770.76 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,306.46 | 2021 | |
| Novo Nordisk INC | $1,304.46 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $1,281.18 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Bayer Healthcare Pharmaceuticals INC. | $1,008.47 | 2021-2025 | |
| Lilly USA, LLC | $996.01 | 2021-2025 | Mounjaro, Jardiance, Emgality |
| Abbott Laboratories | $925.35 | 2022-2025 | Freestyle Libre 3, Proclaim |
| Glaxosmithkline, LLC. | $837.88 | 2021-2024 | Shingrix, Fluarix Quadrivalent, Arexvy |
| Amgen INC. | $645.14 | 2020-2025 | Repatha, Otezla, Evenity |
| Astrazeneca Pharmaceuticals LP | $501.62 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $335.95 | 2021-2025 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $321.28 | 2021-2025 | Verquvo, Belsomra, Gardasil 9 |
| Biohaven Pharmaceutical Holding Company LTD. | $240.79 | 2022 | |
| Corium, LLC | $239.16 | 2021-2024 | Azstarys |
| Antares Pharma, INC. | $206.68 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Janssen Pharmaceuticals, INC | $190.02 | 2021-2023 | Xarelto |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $184.64 | 2021-2025 | |
| Amarin Pharma, INC. | $154.71 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $150.17 | 2024-2025 | Nuzyra |
| Novartis Pharmaceuticals Corporation | $144.13 | 2022-2024 | |
| Gilead Sciences, INC. | $124.99 | 2023 | Epclusa |
| Dexcom, INC. | $120.41 | 2023-2025 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $117.81 | 2021-2022 | |
| Ibsa Pharma INC. | $113.70 | 2021-2025 | Tirosint, Licart, Tirosint |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.40 | 2021-2024 | Jardiance |
| Exact Sciences Corporation | $98.74 | 2023-2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $79.01 | 2023-2024 | Veozah |
| Sanofi-Aventis U.S. LLC | $70.04 | 2021-2023 | |
| Azurity Pharmaceuticals, INC. | $65.06 | 2023 | Adthyza, Edarbi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $61.93 | 2025 | Caplyta |
| Horizon Therapeutics Plc | $57.01 | 2021-2022 | |
| Sanofi Pasteur INC. | $56.26 | 2021-2023 | |
| Kowa Pharmaceuticals America, INC. | $55.32 | 2021-2023 | Seglentis |
| Esperion Therapeutics, INC. | $47.50 | 2023-2025 | Nexletol |
| Arbor Pharmaceuticals, INC. | $42.16 | 2021-2022 | |
| Eisai INC. | $35.95 | 2022 | |
| Idorsia Pharmaceuticals US INC | $35.94 | 2023 | Quviviq |
| Renalytix Ai, INC. | $35.71 | 2024-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Genentech USA, INC. | $28.40 | 2021 | |
| Seqirus USA INC | $26.77 | 2024 | Fluad, Flucelvax |
| Jazz Pharmaceuticals INC. | $21.63 | 2022 | |
| Acclarent, INC | $21.52 | 2023 | Acclarent Aera |
| Halozyme INC | $21.10 | 2023 | |
| Tris Pharma INC | $20.34 | 2022 | |
| Medtronic, INC. | $19.87 | 2023 | Intellis Adaptivestim |
| Inspire Medical Systems, INC. | $18.60 | 2024 | Inspire |
| Noven Therapeutics, LLC | $18.60 | 2023 | Xelstrym |
| Apria Healthcare LLC | $16.88 | 2021 | |
| Ironshore Pharmaceuticals INC. | $15.37 | 2023 | Jornay Pm |
| Vanda Pharmaceuticals INC. | $13.12 | 2023 | Hetlioz |
| Phadia US INC. | $12.79 | 2021 | |
| Cequr Corporation | $11.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bochen Tong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.